Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors
摘要:
Fluorinated isoflavanones and bifunctionalized isoflavanones were synthesized through a one-step gold(I)-catalyzed annulation reaction. These compounds were evaluated for their in vitro inhibitory activities against aromatase in a fluorescence-based enzymatic assay. Selected compounds were tested for their anti-proliferative effects on human breast cancer cell line MCF-7. Compounds 6-methoxy-3-(pyridin-3-yl)chroman-4-one (3c) and 6-fluoro-3-(pyridin-3-yl)chroman-4-one (3e) were identified as the most potent aromatase inhibitors with IC50 values of 2.5 mu M and 0.8 mu M. Therefore, these compounds have great potential for the development of pharmaceutical agents against breast cancer. (C) 2013 Elsevier Ltd. All rights reserved.
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors
作者:Erica Amato、Tony Bankemper、Rebecca Kidney、Thuy Do、Alma Onate、Fathima Shazna Thowfeik、Edward J. Merino、Stefan Paula、Lili Ma
DOI:10.1016/j.bmc.2013.11.045
日期:2014.1
Fluorinated isoflavanones and bifunctionalized isoflavanones were synthesized through a one-step gold(I)-catalyzed annulation reaction. These compounds were evaluated for their in vitro inhibitory activities against aromatase in a fluorescence-based enzymatic assay. Selected compounds were tested for their anti-proliferative effects on human breast cancer cell line MCF-7. Compounds 6-methoxy-3-(pyridin-3-yl)chroman-4-one (3c) and 6-fluoro-3-(pyridin-3-yl)chroman-4-one (3e) were identified as the most potent aromatase inhibitors with IC50 values of 2.5 mu M and 0.8 mu M. Therefore, these compounds have great potential for the development of pharmaceutical agents against breast cancer. (C) 2013 Elsevier Ltd. All rights reserved.